CONTACT
Home
About Us
ImmunoCellular History
Board of Directors
News
Contact Us
Technology
Cancer Immunotherapy
Stem-to-T-Cell Platform
Dendritic Cell-Based Immunotherapeutics
Dendritic Cell-Based Manufacturing
Publications
Resources
Business Development
MENU
Home
About Us
ImmunoCellular History
Board of Directors
News
Contact Us
Technology
Cancer Immunotherapy
Stem-to-T-Cell Platform
Dendritic Cell-Based Immunotherapeutics
Dendritic Cell-Based Manufacturing
Publications
Resources
Business Development
PRESS RELEASES
Wednesday, October 17, 2018
ImmunoCellular Announces Receipt of Notice of Noncompliance with The NYSE American Continued Listing
read more ...
Monday, October 15, 2018
ImmunoCellular Therapeutics Announces Delisting and Deregistration of Common Stock
read more ...
Home
About Us
Technology
Business Development
Terms of Use
|
Privacy Policy
|
Contact
Copyright 2019 by Immunocellular Therapeutics, Ltd.
All Rights Reserved
Login